FDA Critical Path Poster Categories for non-FDA Submitters:
- Biological Endpoints, Biomarkers, Surrogate Markers, and Imaging Technologies
- Predictive Toxicology: Toxicogenomics and Modeling
- Predictive Pharmacokinetics and Pharmacodynamics
- Pharmacogenomics and Proteomics as Product Development Tools
- Innovative Approaches to Design and Evaluation of Clinical Trials
- Process Analytical Technology (PAT) and Pharmaceutical Technology
- Medical Product Design, Characterization, and Manufacturing
- Risk Management, Risk Assessment, and Risk Communication for Drugs and Food
2005 FDA Science Forum |
FDA Chapter, Sigma Xi |
CFSAN |
FDA
Last updated on 2004-NOV-18 by frf